lin-35 encodes the single C. elegans representative of the Retinoblastoma (Rb) protein family, which consist of three members in mammals (pRb,
p107,
p130). Rb has been shown to act in the transcriptional repression of genes with roles in cell cycle control, differentiation and apoptosis. Importantly, components of the "Rb pathway" are mutated or deregulated in most human cancers. Although
lin-35 loss of function results in viable animals that predominantly show a reduced brood size, there are additional defects that become apparent when other genes are inactivated. For instance, a multivulva phenotype is observed when
lin-35 loss of function is combined with inactivation of genes of a second class. Therefore,
lin-35 functions as a SynMuv (synthetic multivulva) class B gene to repress vulval cell fates redundantly with SynMuv class A genes. More recently, redundant functions of
lin-35 in cell-cycle control and pharyngeal morphogenesis have also been discovered (Boxem M and van den Heuvel S, 2001; Fay DS et al, 2003). In order to find additional genes that genetically interact with
lin-35, we are carrying out novel forward and reverse genetic screens for phenotypes that are synthetic, suppressed or enhanced in the context of
lin-35 loss of function. In these screens, we may identify genes that are required for cell survival in the absence of
lin-35 function, revealing potential targets for anti-cancer therapeutics. In addition, genes may be found that act to regulate
lin-35 function, or that act in parallel to
lin-35. In the forward genetic screen of ~2850 haploid genomes, we isolated 20 mutants that showed interaction with
lin-35 Rb. These included 6 SynMuv class A mutants, which validates the screen. For the reverse genetic approach, we have screened more than 10,000 RNAi feeding clones of the ORFeome RNAi library. This RNAi screen has identified a large number of genes, most of which display a feeding RNAi phenotype in
lin-35 mutants but not in wild-type animals. We are using different genetic backgrounds and other gene inactivation methods in secondary screens to further select true candidates. Encouragingly,
cki-1 (known to interact genetically with
lin-35) has already been identified in the reverse screen.